Article
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation.
Journal of cellular and molecular medicine - 1 Aug 2012
Noort W A, Oerlemans M I F J, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens A C, Bühring H J, Doevendans P A, Sluijter J P G
Abstract excerpt
Although mesenchymal stromal cells (MSCs) have been applied clinically to treat cardiac diseases, it is unclear how and to which extent transplanted MSCs exert their beneficial effects. To address these questions, pre-clinical MSC administrations are needed for which pigs appear to be the species of choice. This requires the use of porcine cells to prevent immune rejection. However, it is currently unknown to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
